Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
10 2021
Historique:
received: 27 12 2020
accepted: 04 05 2021
revised: 02 05 2021
pubmed: 12 6 2021
medline: 26 10 2021
entrez: 11 6 2021
Statut: ppublish

Résumé

Rare genetic variants in KDR, encoding the vascular endothelial growth factor receptor 2 (VEGFR2), have been reported in patients with tetralogy of Fallot (TOF). However, their role in disease causality and pathogenesis remains unclear. We conducted exome sequencing in a familial case of TOF and large-scale genetic studies, including burden testing, in >1,500 patients with TOF. We studied gene-targeted mice and conducted cell-based assays to explore the role of KDR genetic variation in the etiology of TOF. Exome sequencing in a family with two siblings affected by TOF revealed biallelic missense variants in KDR. Studies in knock-in mice and in HEK 293T cells identified embryonic lethality for one variant when occurring in the homozygous state, and a significantly reduced VEGFR2 phosphorylation for both variants. Rare variant burden analysis conducted in a set of 1,569 patients of European descent with TOF identified a 46-fold enrichment of protein-truncating variants (PTVs) in TOF cases compared to controls (P = 7 × 10 Rare KDR variants, in particular PTVs, strongly associate with TOF, likely in the setting of different inheritance patterns. Supported by genetic and in vivo and in vitro functional analysis, we propose loss-of-function of VEGFR2 as one of the mechanisms involved in the pathogenesis of TOF.

Identifiants

pubmed: 34113005
doi: 10.1038/s41436-021-01212-y
pii: S1098-3600(21)05126-1
pmc: PMC8486653
doi:

Substances chimiques

KDR protein, human EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1952-1960

Subventions

Organisme : NHLBI NIH HHS
ID : UM1 HL098162
Pays : United States
Organisme : British Heart Foundation
ID : RG/F/21/110050
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : UM1 HL098123
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL131003
Pays : United States
Organisme : British Heart Foundation
ID : RG/15/12/31616
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : UM1 HL128761
Pays : United States
Organisme : British Heart Foundation
ID : CH/13/2/30154
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : UM1 HL128711
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL098147
Pays : United States

Investigateurs

Marc-Phillip Hitz (MP)
Hashim Abdul-Khaliq (H)
Felix Berger (F)
Ingo Dähnert (I)
Sven Dittrich (S)
Anselm Uebing (A)
Brigitte Stiller (B)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1076-81
pubmed: 15644447
Biochem J. 2011 Jul 15;437(2):169-83
pubmed: 21711246
Circulation. 2001 Nov 20;104(21):2565-8
pubmed: 11714651
Development. 2004 Jul;131(13):3217-27
pubmed: 15175244
Eur Respir J. 2020 Apr 3;55(4):
pubmed: 31980491
Circ Res. 2005 Oct 14;97(8):813-20
pubmed: 16166557
Circ Res. 2019 Feb 15;124(4):553-563
pubmed: 30582441
Am J Med Genet A. 2014 Jun;164A(6):1490-5
pubmed: 24677430
Nat Med. 2004 Aug;10(8):849-57
pubmed: 15273746
Hum Mutat. 2013 Dec;34(12):1662-71
pubmed: 24000169
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Lancet. 1998 Jan 31;351(9099):311-6
pubmed: 9652610
Ann Pediatr Cardiol. 2014 May;7(2):86-91
pubmed: 24987252
Nat Genet. 2016 Sep;48(9):1060-5
pubmed: 27479907
Nat Genet. 2017 Nov;49(11):1593-1601
pubmed: 28991257
Biochem Biophys Res Commun. 2008 Oct 24;375(3):287-91
pubmed: 18680722
Nat Struct Mol Biol. 2007 Mar;14(3):249-50
pubmed: 17293873
Genet Med. 2019 Apr;21(4):1001-1007
pubmed: 30232381
Development. 2011 Nov;138(21):4777-87
pubmed: 21989917
Blood. 2006 Oct 15;108(8):2624-31
pubmed: 16638931
Nat Commun. 2018 Apr 12;9(1):1416
pubmed: 29650961
Blood. 2011 Jan 27;117(4):1425-35
pubmed: 21063020
Nature. 1995 Jul 6;376(6535):62-6
pubmed: 7596435
Orphanet J Rare Dis. 2009 Jan 13;4:2
pubmed: 19144126
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Mol Cell Biol. 2012 Oct;32(19):3802-13
pubmed: 22801374
J Biol Chem. 1997 Dec 19;272(51):32521-7
pubmed: 9405464
J Am Coll Cardiol. 1998 Aug;32(2):492-8
pubmed: 9708481
PLoS One. 2015 Sep 18;10(9):e0138525
pubmed: 26382615
Circulation. 2020 Feb 4;141(5):387-398
pubmed: 31983221
J Mol Cell Cardiol. 2007 Dec;43(6):677-85
pubmed: 17643447
EMBO J. 2001 Jun 1;20(11):2768-78
pubmed: 11387210
Cell Signal. 2007 Oct;19(10):2003-12
pubmed: 17658244
Science. 2015 Dec 4;350(6265):1262-6
pubmed: 26785492

Auteurs

Doris Škorić-Milosavljević (D)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Najim Lahrouchi (N)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Fernanda M Bosada (FM)

Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Gregor Dombrowsky (G)

Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.

Simon G Williams (SG)

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Robert Lesurf (R)

Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.

Fleur V Y Tjong (FVY)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Roddy Walsh (R)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Ihssane El Bouchikhi (I)

Laboratory of Medical Genetics and Oncogenetics, HASSAN II University Hospital, Fez, Morocco.

Jeroen Breckpot (J)

Center for Human Genetics Leuven and Catholic University Leuven, Leuven, Belgium.

Enrique Audain (E)

Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.

Aho Ilgun (A)

Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Leander Beekman (L)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Ilham Ratbi (I)

Centre de Recherche en Génomique des Pathologies Humaines (GENOPATH), Faculté de Médecine et de Pharmacie, Mohammed V University of Rabat, Rabat, Morocco.
Département de génétique médicale, Institut National d'Hygiène, Rabat, Morocco.

Alanna Strong (A)

Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Maximilian Muenke (M)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Solveig Heide (S)

Département de génétique, Hôpital Pitié-Salpêtrière, APHP Sorbonne Université, Paris, France.

Alison M Muir (AM)

Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA.

Mariam Hababa (M)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Laura Cross (L)

Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, MO, USA.

Dihong Zhou (D)

Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, MO, USA.

Tomi Pastinen (T)

Center for Pediatric Genomic Medicine, Children's Mercy Hospital and School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.

Elaine Zackai (E)

Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Samir Atmani (S)

HASSAN II University Hospital, Fez, Morocco.
University of Sidi Mohammed Ben Abdellah, Fez, Morocco.

Karim Ouldim (K)

Faculty of Medicine and Pharmacy, Medical Genetics and Oncogenetics Unit, Sidi Mohamed Ben Abdellah University, Fez, Morocco.

Najlae Adadi (N)

Centre de Recherche en Génomique des Pathologies Humaines (GENOPATH), Faculté de Médecine et de Pharmacie, Mohammed V University of Rabat, Rabat, Morocco.
Département de génétique médicale, Institut National d'Hygiène, Rabat, Morocco.

Katharina Steindl (K)

Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.

Anita Rauch (A)

Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.

David Brook (D)

University of Nottingham, Queen's Medical Centre, Nottingham, UK.

Anna Wilsdon (A)

University of Nottingham, Queen's Medical Centre, Nottingham, UK.

Irene Kuipers (I)

Department of Pediatric Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Nico A Blom (NA)

Department of Pediatric Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Department of Pediatric Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Barbara J Mulder (BJ)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Heather C Mefford (HC)

Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA.

Boris Keren (B)

Département de génétique, Hôpital Pitié-Salpêtrière, APHP Sorbonne Université, Paris, France.

Pascal Joset (P)

Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.

Paul Kruszka (P)

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.

Isabelle Thiffault (I)

Center for Pediatric Genomic Medicine, Children's Mercy Hospital and School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.

Sarah E Sheppard (SE)

Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Amy Roberts (A)

Department of Cardiology, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Elisabeth M Lodder (EM)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Department of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Bernard D Keavney (BD)

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Sally-Ann B Clur (SB)

Department of Pediatric Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Seema Mital (S)

The Hospital for Sick Children, Toronto, ON, Canada.
University of Toronto, Toronto, ON, Canada.

Marc-Philip Hitz (MP)

Department of Congenital Heart Disease and Pediatric Cardiology, Universitätsklinikum Schleswig-Holstein Kiel, Kiel, Germany.
DZHK (German Centre for Cardiovascular Research) Partner Site, Kiel, Germany.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.

Vincent M Christoffels (VM)

Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Alex V Postma (AV)

Department of Medical Biology, Amsterdam University Medical Center, Amsterdam, The Netherlands. a.v.postma@amsterdamumc.nl.
Department of Clinical Genetics, Amsterdam University Medical Center, Amsterdam, The Netherlands. a.v.postma@amsterdamumc.nl.

Connie R Bezzina (CR)

Department of Clinical and Experimental Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands. c.r.bezzina@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH